Friday, October 15, 2010

10/16 TE-RegenMed-StemCell feed

     
    TE-RegenMed-StemCell feed    
   
Development of a porcine delayed wound-healing model and its use in testing a novel cell-based therapy.
October 15, 2010 at 2:36 PM
 
Related Articles

Development of a porcine delayed wound-healing model and its use in testing a novel cell-based therapy.

Int J Radiat Oncol Biol Phys. 2010 Nov 1;78(3):888-96

Authors: Hadad I, Johnstone BH, Brabham JG, Blanton MW, Rogers PI, Fellers C, Solomon JL, Merfeld-Clauss S, DesRosiers CM, Dynlacht JR, Coleman JJ, March KL

PURPOSE: A delayed full-thickness wound-healing model was developed and used for examining the capacity of adipose-derived stem cells (ASCs), either alone or in platelet-rich fibrin gels, to promote healing. METHODS AND MATERIALS: Four pigs received electron beam radiation to the dorsal skin surface. Five weeks after radiation, subcutaneous fat was harvested from nonirradiated areas and processed to yield ASCs. Two weeks later, 28 to 30 full-thickness 1.5-cm(2) wounds were made in irradiated and nonirradiated skin. Wounds were treated with either saline solution, ASCs in saline solution, platelet-rich plasma (PRP) fibrin gel, ASCs in PRP, or non-autologous green fluorescence protein-labeled ASCs. RESULTS: The single radiation dose produced a significant loss of dermal microvasculature density (75%) by 7 weeks. There was a significant difference in the rate of healing between irradiated and nonirradiated skin treated with saline solution. The ASCs in PRP-treated wounds exhibited a significant 11.2% improvement in wound healing compared with saline solution. Enhancement was dependent on the combination of ASCs and PRP, because neither ASCs nor PRP alone had an effect. CONCLUSIONS: We have created a model that simulates the clinically relevant late radiation effects of delayed wound healing. Using this model, we showed that a combination of ASCs and PRP improves the healing rates of perfusion-depleted tissues, possibly through enhancing local levels of growth factors.

PMID: 20708345 [PubMed - indexed for MEDLINE]

   
   
Adipose tissue-derived stem cells: the friendly side of a classic cardiovascular foe.
October 15, 2010 at 2:36 PM
 
Related Articles

Adipose tissue-derived stem cells: the friendly side of a classic cardiovascular foe.

J Cardiovasc Transl Res. 2008 Mar;1(1):55-63

Authors: Sanz-Ruiz R, Santos ME, Muñoa MD, Martín IL, Parma R, Fernández PL, Fernández-Avilés F

Recently, the existence of a population of stem cells located in the adipose tissue has been observed. Adipose-derived stem cells are able to differentiate into multiple cell lineages including cardiac myocytes. Hence, adipose-derived cells are emerging as a new source of adult stem cells for cardiovascular repair. In this review, we discuss the basic principles of adipose-derived stem cells (types and characteristics, obtention processes, immunophenotypic characterization, and cell potency), the initial experimental studies, and the currently ongoing clinical trials.

PMID: 20559958 [PubMed - indexed for MEDLINE]

   
   
Final Wrap-up for Blue Ribbon Review of California Stem Cell Agency
October 15, 2010 at 1:37 PM
 
SAN FRANCISCO – The blue-ribbon panel reviewing the operations of the $3 billion California stem cell agency is wrapping up its on-site sessions today and framing the general outlines of what it wants to say.

The panel conducted a final, one-hour public comment session that attracted only one person – yours truly. The bulk of this week's hearings were conducted behind closed-doors and were
   
     
 
This email was sent to regenmd@gmail.com.
Delivered by Feed My Inbox
230 Franklin Road Suite 814 Franklin, TN 37064
Account Login
Unsubscribe Here Feed My Inbox
 
     

No comments: